Register for streaming realtime charts, analysis tools, and prices.

Get Started

DSGN Design Therapeutics Inc

6.25

0.26 (4.34%)

Dec 21 2024 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

08/09/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Arsani William

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Design Therapeutics (NASDAQ:DSGN)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Design Therapeutics Charts.

Design Therapeutics (NASDAQ:DSGN)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Design Therapeutics Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Design Therapeutics Inc News

More Design Therapeutics Inc News Articles

Asia Broadband (PK)

North Bay Resources (PK)

Lightwave Logic

Elite Pharmaceuticals (QB)

Anavex Life Sciences

Digital Brand Media and ... (PK)

Kraig Biocraft Laborator... (QB)

Bioelectronics (PK)

Good Vibrations Shoes (PK)

Northwest Biotherapeutics (QB)

Fannie Mae (QB)

Delayed Upgrade Clock